TFTengjiao Fan

Tengjiao Fan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tengjiao Fan has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Guohui Sun

    Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China

    5 shared publications
  • Lijiao Zhao

    Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, China

    5 shared publications
  • Rugang Zhong

    Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing, People’s Republic of China

    5 shared publications
  • Na Zhang

    Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing, P. R. China

    3 shared publications
  • Ting Ren

    Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing, People’s Republic of China

    2 shared publications
  • Dorothy J. Donnelly

    Chemistry Department, Trinity College, D02 PN40 Dublin, Ireland

    1 shared publication

Latest Publications

  • Discovery of potential RSV fusion protein inhibitors from benzimidazole derivatives using QSAR, molecular docking, and ADMET evaluation methods

    by Yini Xie, Runqing Jia, Tengjiao Fan, Shuo Chen, Ting Ren, Na Zhang, Lijiao Zhao, Rugang Zhong, Guohui Sun

    Respiratory syncytial virus (RSV) is a leading cause of severe lower respiratory tract infections in infants, the elderly, and immunocompromised individuals worldwide. The pathogenic mechanism of RSV is closely linked to the membrane fusion process mediated by its fusion glycoprotein (F protein), which has consequently emerged as a critical target for developing anti-RSV therapeutics. At present, there is a lack of specific clinical treatments for RSV, and traditional drug discovery approaches are often time-consuming and expensive. In this context, quantitative structure–activity relationship (QSAR)–assisted drug design offers notable advantages. In this study, we collected a dataset consisting of 156 benzimidazole derivatives against F protein from publicly available sources. Transferable, reproducible, and interpretable 2D-QSAR inhibitory activity and cytotoxicity prediction models were constructed using Genetic Algorithm (GA) and Multiple Linear Regression (MLR). Following rigorous statistical validation, the best inhibitory activity model achieved R2 = 0.8740, \({Q}_{\text{Loo}}^{2}\) = 0.8272, \({R}_{\text{test}}^{2}\) = 0.8273, \({Q}_{\text{Fn}}^{2}\) = 0.8033–0.8492, CCCtest = 0.8782, MAEtest = 0.3014; the best cytotoxicity model was of R2 = 0.7573, \({Q}_{\text{Loo}}^{2}\) = 0.6926, \({R}_{\text{test}}^{2}\) = 0.7707, \({Q}_{\text{Fn}}^{2}\) = 0.7298–0.8656, CCCtest = 0.8639, MAEtest = 0.1342. The optimal inhibitory activity model was used to perform virtual screening on 912 benzimidazole derivatives retrieved from the PubChem, and identified 234 derivatives with better inhibitory activity than the reference JNJ-53718678. Among these, 152 derivatives were found to possess better docking binding energies than JNJ-53718678. Furthermore, we used the optimal toxicity model to assess their cytotoxicity, and identified 23 derivatives with predicted cytotoxicity lower than that of JNJ-53718678. Finally, through drug-likeness evaluation, ADMET analysis and molecular dynamics simulation, we obtained eight potential RSV inhibitors with higher inhibitory activity, lower cytotoxicity, and better pharmacokinetic properties compared to JNJ-53718678. Graphical abstract


  • Assessment of the rat acute oral toxicity of quinoline-based pharmaceutical scaffold molecules using QSTR, q-RASTR and machine learning methods

    by Jianing Xu, Ting Ren, Feifan Li, Shuo Chen, Tengjiao Fan, Lijiao Zhao, Rugang Zhong, Guohui Sun, Ning Lin

    Quinoline is a common pharmaceutical scaffold molecule known for its wide range of biological and pharmacological activities, including antimalarial, antitumor, and antibacterial effects. With the continuous discovery of new bioactivities, there is a growing demand for the design and development of novel quinoline-based drugs. However, drug development is time-consuming and costly, and traditional toxicity testing methods such as animal experiments are resource-intensive. In the context of the 3Rs (Replacement, Reduction, Refinement) principle in animal research, quantitative structure–activity/toxicity relationship (QSAR/QSTR) modeling has become one of the most widely used methods for drug design and validation. This study collected acute oral toxicity data in rat for 33 quinoline derivatives and established a transferable, reproducible and interpretable QSTR model based on 2D molecular descriptors, following the OECD principles for model validation. Both internal and external validations were performed. The results demonstrated that the model possesses high goodness-of-fit, strong robustness, and excellent predictive power. Applicability domain (AD) analysis showed that the model has a broad range of applicability. Furthermore, the model’s predictive performance was verified and enhanced using quantitative read-across structure–toxicity relationship (q-RASTR) and machine learning (ML) methods. Mechanistic interpretation provided detailed insights into the relationships between molecular descriptors and toxicity. Notably, for the first time, the model was applied for a true external dataset consisting of 1995 molecules lacking experimental values, thereby validating its extrapolation ability. Overall, the developed QSTR model exhibits good stability and predictive performance, offering theoretical support for the risk assessment and rational design of quinoline-based compounds. Graphical Abstract


  • Open Access

    QSAR and Chemical Read-Across Analysis of 370 Potential MGMT Inactivators to Identify the Structural Features Influencing Inactivation Potency

    by Guohui Sun, Peiying Bai, Tengjiao Fan, Lijiao Zhao, Rugang Zhong, R. Stanley McElhinney, T. Brian H. McMurry, Dorothy J. Donnelly, Joan E. McCormick, Jane Kelly, et al.

    O6-methylguanine-DNA methyltransferase (MGMT) constitutes an important cellular mechanism for repairing potentially cytotoxic DNA damage induced by guanine O6-alkylating agents and can render cells highly resistant to certain cancer chemotherapeutic drugs. A wide variety of potential MGMT inactivators have been designed and synthesized for the purpose of overcoming MGMT-mediated tumor resistance. We determined the inactivation potency of these compounds against human recombinant MGMT using [3H]-methylated-DNA-based MGMT inactivation assays and calculated the IC50 values. Using the results of 370 compounds, we performed quantitative structure–activity relationship (QSAR) modeling to identify the correlation between the chemical structure and MGMT-inactivating ability. Modeling was based on subdividing the sorted pIC50 values or on chemical structures or was random. A total of nine molecular descriptors were presented in the model equation, in which the mechanistic interpretation indicated that the status of nitrogen atoms, aliphatic primary amino groups, the presence of O-S at topological distance 3, the presence of Al-O-Ar/Ar-O-Ar/R..O..R/R-O-C=X, the ionization potential and hydrogen bond donors are the main factors responsible for inactivation ability. The final model was of high internal robustness, goodness of fit and prediction ability (R2pr = 0.7474, Q2Fn = 0.7375–0.7437, CCCpr = 0.8530). After the best splitting model was decided, we established the full model based on the entire set of compounds using the same descriptor combination. We also used a similarity-based read-across technique to further improve the external predictive ability of the model (R2pr = 0.7528, Q2Fn = 0.7387–0.7449, CCCpr = 0.8560). The prediction quality of 66 true external compounds was checked using the “Prediction Reliability Indicator” tool. In summary, we defined key structural features associated with MGMT inactivation, thus allowing for the design of MGMT inactivators that might improve clinical outcomes in cancer treatment.


  • Open Access

    Identification of Pharmacophoric Fragments of DYRK1A Inhibitors Using Machine Learning Classification Models

    by Mengzhou Bi, Zhen Guan, Tengjiao Fan, Na Zhang, Jianhua Wang, Guohui Sun, Lijiao Zhao, Rugang Zhong

    Dual-specific tyrosine phosphorylation regulated kinase 1 (DYRK1A) has been regarded as a potential therapeutic target of neurodegenerative diseases, and considerable progress has been made in the discovery of DYRK1A inhibitors. Identification of pharmacophoric fragments provides valuable information for structure- and fragment-based design of potent and selective DYRK1A inhibitors. In this study, seven machine learning methods along with five molecular fingerprints were employed to develop qualitative classification models of DYRK1A inhibitors, which were evaluated by cross-validation, test set, and external validation set with four performance indicators of predictive classification accuracy (CA), the area under receiver operating characteristic (AUC), Matthews correlation coefficient (MCC), and balanced accuracy (BA). The PubChem fingerprint-support vector machine model (CA = 0.909, AUC = 0.933, MCC = 0.717, BA = 0.855) and PubChem fingerprint along with the artificial neural model (CA = 0.862, AUC = 0.911, MCC = 0.705, BA = 0.870) were considered as the optimal modes for training set and test set, respectively. A hybrid data balancing method SMOTETL, a combination of synthetic minority over-sampling technique (SMOTE) and Tomek link (TL) algorithms, was applied to explore the impact of balanced learning on the performance of models. Based on the frequency analysis and information gain, pharmacophoric fragments related to DYRK1A inhibition were also identified. All the results will provide theoretical supports and clues for the screening and design of novel DYRK1A inhibitors.